AIP
AKYA

Ameritas Investment Partners’s Akoya BioSciences AKYA Stock Holding History

Ameritas Investment Partners’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,199
Closed -$1.67K – 3204
2025
Q1 		$1.67K Hold
1,199
– – ﹤0.01% 3079
2024
Q4 		$2.75K Hold
1,199
– – ﹤0.01% 3087
2024
Q3 		$3.26K Hold
1,199
– – ﹤0.01% 3077
2024
Q2 		$2.81K Hold
1,199
– – ﹤0.01% 3079
2024
Q1 		$5.62K Hold
1,199
– – ﹤0.01% 2934
2023
Q4 		$5.85K Hold
1,199
– – ﹤0.01% 2951
2023
Q3 		$5.58K Hold
1,199
– – ﹤0.01% 2969
2023
Q2 		$8.86K Hold
1,199
– – ﹤0.01% 2948
2023
Q1 		$9.81K Hold
1,199
– – ﹤0.01% 2731
2022
Q4 		$12.7K Hold
1,199
– – ﹤0.01% 2738
2022
Q3 		$14K Buy
1,199
+600
+100% +$7.9K ﹤0.01% 2666
2022
Q2 		$7K Hold
599
– – ﹤0.01% 2906
2022
Q1 		$7K Hold
599
– – ﹤0.01% 2883
2021
Q4 		$9K Hold
599
– – ﹤0.01% 2920
2021
Q3 		$8K Hold
599
– – ﹤0.01% 2984
2021
Q2 		$12K Buy
+599
New +$12.4K ﹤0.01% 2897

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCA
Peddock Capital Advisors Braintree, Massachusetts $501M AUM 29.8% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Ameritas Investment Partners's AKYA Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Akoya BioSciences (AKYA) in Q2 2025, closing a stake of 1,199 shares — an estimated $1.67K sold.

Ameritas Investment Partners first reported a position in AKYA in Q2 2021 and held it in 16 quarters. The position peaked at $14K in Q3 2022. 58 funds tracked by Wall St. Rank hold AKYA as of Q2 2025.

  • Ameritas Investment Partners reported no remaining Akoya BioSciences position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 1,199 Akoya BioSciences shares in Q2 2025, an estimated $1.67K.
  • Ameritas Investment Partners first reported a position in Akoya BioSciences in Q2 2021 and held it in 16 quarters.
  • Ameritas Investment Partners's Akoya BioSciences position peaked at $14K in Q3 2022.
  • 58 funds tracked by Wall St. Rank held Akoya BioSciences as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.